212 related articles for article (PubMed ID: 33537526)
1. Protease-activated receptors: An illustrated review.
Han X; Nieman MT; Kerlin BA
Res Pract Thromb Haemost; 2021 Jan; 5(1):17-26. PubMed ID: 33537526
[TBL] [Abstract][Full Text] [Related]
2. The domino effect triggered by the tethered ligand of the protease activated receptors.
Han X; Nieman MT
Thromb Res; 2020 Dec; 196():87-98. PubMed ID: 32853981
[TBL] [Abstract][Full Text] [Related]
3. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry.
Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F
Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167
[TBL] [Abstract][Full Text] [Related]
4. Biased signaling of protease-activated receptors.
Zhao P; Metcalf M; Bunnett NW
Front Endocrinol (Lausanne); 2014; 5():67. PubMed ID: 24860547
[TBL] [Abstract][Full Text] [Related]
5. Allosteric modulation of protease-activated receptor signaling.
Canto I; Soh UJ; Trejo J
Mini Rev Med Chem; 2012 Aug; 12(9):804-11. PubMed ID: 22681248
[TBL] [Abstract][Full Text] [Related]
6. Cofactoring and dimerization of proteinase-activated receptors.
Lin H; Liu AP; Smith TH; Trejo J
Pharmacol Rev; 2013; 65(4):1198-213. PubMed ID: 24064459
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking.
Trejo J
J Pharmacol Exp Ther; 2003 Nov; 307(2):437-42. PubMed ID: 12966163
[TBL] [Abstract][Full Text] [Related]
8. How the protease thrombin talks to cells.
Coughlin SR
Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11023-7. PubMed ID: 10500117
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling by protease-activated receptors: implications for therapeutic targeting.
Sidhu TS; French SL; Hamilton JR
Int J Mol Sci; 2014 Apr; 15(4):6169-83. PubMed ID: 24733067
[TBL] [Abstract][Full Text] [Related]
10. Human osteoarthritis knee joint synovial fluids cleave and activate Proteinase-Activated Receptor (PAR) mediated signaling.
Chandrabalan A; Firth A; Litchfield RB; Appleton CT; Getgood A; Ramachandran R
Sci Rep; 2023 Jan; 13(1):1124. PubMed ID: 36670151
[TBL] [Abstract][Full Text] [Related]
11. Endosomal signaling by protease-activated receptors.
Grimsey N; Lin H; Trejo J
Methods Enzymol; 2014; 535():389-401. PubMed ID: 24377935
[TBL] [Abstract][Full Text] [Related]
12. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
Yonamine CM; Kondo MY; Nering MB; Gouvêa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
[TBL] [Abstract][Full Text] [Related]
13. Molecular basis of protease-activated receptor 1 signaling diversity.
Willis Fox O; Preston RJS
J Thromb Haemost; 2020 Jan; 18(1):6-16. PubMed ID: 31549766
[TBL] [Abstract][Full Text] [Related]
14. Progress in the understanding of protease-activated receptors.
Gabazza EC; Taguchi O; Kamada H; Hayashi T; Adachi Y; Suzuki K
Int J Hematol; 2004 Feb; 79(2):117-22. PubMed ID: 15005337
[TBL] [Abstract][Full Text] [Related]
15. Functional role of protease activated receptors in vascular biology.
Alberelli MA; De Candia E
Vascul Pharmacol; 2014 Aug; 62(2):72-81. PubMed ID: 24924409
[TBL] [Abstract][Full Text] [Related]
16. Protease-activated receptors: the role of cell-surface proteolysis in signalling.
Cottrell GS; Coelho AM; Bunnett NW
Essays Biochem; 2002; 38():169-83. PubMed ID: 12463169
[TBL] [Abstract][Full Text] [Related]
17. Protease activated receptors in cardiovascular function and disease.
Barnes JA; Singh S; Gomes AV
Mol Cell Biochem; 2004 Aug; 263(1):227-39. PubMed ID: 27520681
[TBL] [Abstract][Full Text] [Related]
18. Protease-activated receptors in hemostasis.
Nieman MT
Blood; 2016 Jul; 128(2):169-77. PubMed ID: 27127302
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated receptors in kidney disease progression.
Palygin O; Ilatovskaya DV; Staruschenko A
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1140-F1144. PubMed ID: 27733370
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
